The coronavirus has arrived in the heart of Europe. In the meantime, Germany is also preparing for a pandemic. Some would say: too late. As new cases of infected people are being reported every day throughout Germany: in North Rhine-Westphalia, Hamburg, Hessen and elsewhere. In a globalised world and open social structures, it is difficult to prevent a spread. This makes it even more important now and in the future to significantly accelerate the production of vaccines and adapt them to the pace and location-independence of a globalised world - a process developed by the Münster-based biotech company Cilian AG could make the decisive difference.